NCT02811718View on ClinicalTrials.gov

Resiliency Training for Patients With NF2 Via Videoconferencing With Skype

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

June 30, 2018

Study Completion Date

July 31, 2018

Conditions
Neurofibromatosis 2
Interventions
BEHAVIORAL

Stress Management Group 1

Subjects will attend group stress management sessions via Skype once weekly for 8 weeks and learn stress/NF symptoms managements techniques.

BEHAVIORAL

Stress Management Group 2

Subjects will attend group stress management sessions via Skype once weekly for 8 weeks and learn stress/NF symptoms managements techniques.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

The Children's Tumor Foundation

OTHER

lead

Massachusetts General Hospital

OTHER

NCT02811718 - Resiliency Training for Patients With NF2 Via Videoconferencing With Skype | Biotech Hunter | Biotech Hunter